Vaccination coverage against human papilloma virus (HPV) in the United States remains
low. This study aimed to identify factors associated with initiation of HPV vaccination among …

Objective: To assess HPV vaccination among US adults and children and to identify
characteristics associated with HPV vaccination. Methods: We used the 2010 Behavioral …

Purpose Human papillomavirus (HPV) vaccination in the United States has been
recommended for girls since 2006 and for boys since 2011. However, settings of receiving …

To examine health providers' perceived barriers, supports, and vaccination actions in
delivering the HPV vaccine to females ages 9–17 in four states. Differences in providers' …

Though vaccine uptake and public support have risen since the release of the first HPV
vaccines, the United States has far lower initiation and completion rates for the HPV vaccine …

Introduction Half of all new human papillomavirus (HPV) infections occur in adolescents and
young adults, and this population has poor HPV vaccination rates. Rural areas of the US …

Human papillomavirus (HPV) vaccination among adolescents in rural, western North
Carolina (NC) remains suboptimal. Data are needed to understand the barriers to HPV …

The Advisory Committee on Immunization Practices recommends routine human
papillomavirus (HPV) immunization for 11-to 12-year-old adolescents. In 2008, Louisiana …

Introduction/Objectives: Annually, HPV infections result in $775 million in direct medical
costs and approximately 46 000 new cases of HPV-associated cancers. Safe and highly …

Background The human papillomavirus (HPV) vaccine is recommended for all adolescents
age 11–12 years. HPV vaccine coverage remains suboptimal in the United States though …